A rating of 51 puts Cronos Group Inc (CRON) near the middle of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Cronos Group Inc's score of 51 means it scores higher than 51% of stocks in the industry. Cronos Group Inc also received an overall rating of 22, putting it above 22% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 133 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 22 would rank higher than 22 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Cronos Group Inc Stock Today?
Cronos Group Inc (CRON) stock is trading at $6.56 as of 2:22 PM on Friday, Jul 31, a decline of -$0.09, or -1.35% from the previous closing price of $6.65. The stock has traded between $6.55 and $6.92 so far today. Volume today is below average. So far 2,580,142 shares have traded compared to average volume of 3,886,060 shares.
